Suscribirse

Liver transplantation for critically ill cirrhotic patients: Results from the French transplant registry - 06/07/22

Doi : 10.1016/j.clinre.2021.101817 
Thierry Artzner a, , Camille Legeai b, Corinne Antoine b, Carine Jasseron b, Baptiste Michard a, François Faitot a, Francis Schneider a, Philippe Bachellier a

Collaborators1

  Liver transplant advisory group, clinical centers and transplant unit surgical and medical supervisors (see the list of participants attached in Acknowledgements).

a Hôpitaux Universitaires de Strasbourg, Strasbourg, France 
b Agence de la Biomédecine, Saint Denis, France 

Corresponding author.

Highlights

Cirrhotic patients transplanted from the ICU have increased post-transplant mortality.
Identifying patients transplanted from the ICU who have poor post-transplant prognosis is essential in order to balance individual and collective utility.
Among cirrhotic patients transplanted from the ICU, four independent factors were associated with poorer prognosis: recipient age, diabetes, intubation prior to transplantation and donor age.
The rate of cirrhotic patients transplanted from the ICU varies greatly among French centers, reflecting diverging approaches to the complex issue of transplanting critically ill cirrhotic patients.

El texto completo de este artículo está disponible en PDF.

Abstract

This study describes the population of cirrhotic patients who were transplanted from the ICU in France, identifying pre-transplant risk factors of post-transplant mortality and describing geographic variations in ICU transplant activity.

Cirrhotic patients transplanted between 2008 and 2018 were included through the national transplant registry. The demographic, clinical and biological characteristics of the patients transplanted from the ICU were compared to cirrhotic patients who were transplanted from home or from the hospital. Risk factors of post-transplant one-year mortality were identified in uni- and multivariable analysis within the population transplanted from the ICU. Funnel plots were used to illustrate center-specific differences in ICU transplant activity.

1,047 cirrhotic patients were transplanted from the ICU during the study period. While the national rate of transplants performed from the ICU was 14.3% the absolute number and the rate of cirrhotic patients transplanted from the ICU varied significantly from one center to another, ranging from 6.6% to 22.8% (p < 0.05). Three recipient-associated independent risk factors one-year post-LT mortality were identified in the population transplanted from the ICU: age > 50 years (HR 1.65, 95%CI 1.16–2.36), p = 0.005), diabetes (HR 1.46, 95%CI 1.07–1.98, p = 0.02) and intubation (HR2.12, 95%CI 1.62-2.78), p < 0.001). Donor age was also independently associated with mortality (HR 1.01, 95%CI 1.01–1.02, p < 0.001). Funnel plots showed significant differences in the proportion of patients transplanted from the ICU and the distribution of risk factors across French transplant centers, especially the inclination to transplant intubated patients.

This study underlines the increased post-transplant mortality among cirrhotic patients transplanted from the ICU. It identifies four clinically pertinent independent risk factors associated with post-transplant mortality in this specific sub-group of transplant candidates. Finally, it illustrates how diverse the landscape of liver transplantation for critically ill cirrhotic patients is across a single country, despite a unified allocation algorithm.

El texto completo de este artículo está disponible en PDF.

Abbreviations : ACLF, BMI, HCC, ICU, LT, MELD


Esquema


© 2021  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 46 - N° 6

Artículo 101817- juin 2022 Regresar al número
Artículo precedente Artículo precedente
  • Risk prediction models for hepatocellular carcinoma in chronic hepatitis B patients on antiviral therapy: A meta-analysis
  • Yueli Shen, Jiao Liu, Zhi Han, Weiyun Jiang, Huaizhong Cui, Yunhao Xun
| Artículo siguiente Artículo siguiente
  • SIB-IMRT combined with apatinib for unresectable hepatocellular carcinoma in patients with poor response to transarterial chemoembolization
  • Xuefen Liu, Jiangping Luo, Longbin Zhang, Fan Yang, Dong Peng

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.